THC vs. XBI
Compare and contrast key facts about Tenet Healthcare Corporation (THC) and SPDR S&P Biotech ETF (XBI).
XBI is a passively managed fund by State Street that tracks the performance of the S&P Biotechnology Select Industry Index. It was launched on Feb 6, 2006.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: THC or XBI.
Correlation
The correlation between THC and XBI is 0.39, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
THC vs. XBI - Performance Comparison
Key characteristics
THC:
1.74
XBI:
-0.01
THC:
2.68
XBI:
0.16
THC:
1.32
XBI:
1.02
THC:
1.07
XBI:
-0.01
THC:
7.30
XBI:
-0.03
THC:
9.07%
XBI:
8.75%
THC:
38.00%
XBI:
25.25%
THC:
-98.28%
XBI:
-63.89%
THC:
-37.33%
XBI:
-49.34%
Returns By Period
In the year-to-date period, THC achieves a 3.67% return, which is significantly higher than XBI's -2.32% return. Over the past 10 years, THC has outperformed XBI with an annualized return of 11.58%, while XBI has yielded a comparatively lower 3.07% annualized return.
THC
3.67%
1.08%
-2.99%
59.26%
29.30%
11.58%
XBI
-2.32%
-3.62%
-11.03%
1.20%
-1.35%
3.07%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
THC vs. XBI — Risk-Adjusted Performance Rank
THC
XBI
THC vs. XBI - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Tenet Healthcare Corporation (THC) and SPDR S&P Biotech ETF (XBI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
THC vs. XBI - Dividend Comparison
THC has not paid dividends to shareholders, while XBI's dividend yield for the trailing twelve months is around 0.15%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
THC Tenet Healthcare Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
XBI SPDR S&P Biotech ETF | 0.15% | 0.15% | 0.02% | 0.00% | 0.04% | 0.20% | 0.00% | 0.28% | 0.24% | 0.26% | 0.61% | 1.07% |
Drawdowns
THC vs. XBI - Drawdown Comparison
The maximum THC drawdown since its inception was -98.28%, which is greater than XBI's maximum drawdown of -63.89%. Use the drawdown chart below to compare losses from any high point for THC and XBI. For additional features, visit the drawdowns tool.
Volatility
THC vs. XBI - Volatility Comparison
Tenet Healthcare Corporation (THC) has a higher volatility of 8.36% compared to SPDR S&P Biotech ETF (XBI) at 7.86%. This indicates that THC's price experiences larger fluctuations and is considered to be riskier than XBI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.